Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Shalby Ltd (SHALBY) Share Price & Fundamentals

Company Overview

Founded Year

2004

Listed Year

2017

Headquarter

Ahmedabad, Gujarat, India

MD/CEO

Dr. Vikram Shah, renowned orthopedic surgeon and founder, leads with a focus on innovation and expansion.

Website

https://www.shalby.org/

Company Facts

What we do

Shalby Limited is a leading Indian multi-specialty hospital chain providing affordable, high-quality healthcare including orthopedics, cardiology, oncology, and transplants across 15 hospitals.

Founded in

2,004

Market share

Largest corporate hospital group in Western and Central India with 2300+ beds over 12 cities; global leader in joint replacements.

Problem solved

Provides advanced tertiary and quaternary healthcare addressing orthopedic and multi-specialty medical needs affordably.

Top clients or who we serve

Serves B2C patients across India and international patients via OPD clinics in Africa and Middle East.

Key management

Dr. Vikram Shah, renowned orthopedic surgeon and founder, leads with a focus on innovation and expansion.

Our journey and innovations

Evolved from a 6-bed hospital in 1994 to a 15-hospital network; pioneered digital transformation and advanced robotic surgeries.

Where we operate

Operates primarily in India across 12 cities and internationally in Africa, Middle East, and Southeast Asia.

Top products or what we offer

Comprehensive hospital services including orthopedics, cardiac care, neurology, oncology, renal transplants, and implant manufacturing.

Top brands

Shalby Hospitals, Shalby International, Shalby MedTech implants (including Tahoe Unicompartmental Knee System - TUKS)

Raw materials needed

Raw materials for implant manufacturing include medical-grade metals and biomaterials sourced globally.

Raw materials supplier

Implant raw materials sourced via subsidiaries in USA, Singapore, and India.

Recurring vs cyclical contribution

Revenue is largely recurring from hospital operations, with implant manufacturing adding manufacturing revenue stream.

Our industry position

Leading regional hospital chain with top market share in orthopedics and expanding multi-specialty care.

Financial highlights

FY25 consolidated revenue ₹1087 Cr; PAT ₹6.22 Cr; hospital segment EBITDA ₹96 Cr; continuing growth in revenue and capacity.

Geographical revenue split

Revenue majorly from India with growing contributions from international operations in Africa and Middle East.

Order book

-

Whats driving growth

Growth driven by expansion of hospitals, new specialty launches, advanced surgical technology, and implant business innovation.

Our future plans

Launching 175-bed Mumbai facility by FY30; expanding implant products globally; increasing AI and robotic surgery capabilities.

Our green promise

Implements energy conservation measures, sustainable building design, and water conservation in new hospital projects.

Our people and values

Employs 4600+ staff focused on patient care, technological excellence, and ethical governance.

Key challenges ahead

Challenges include scaling operations sustainably, managing costs, and navigating healthcare regulations.

Interesting facts

Global leader in joint replacement surgeries with 175,000+ done; first hospital group with NABH ambulance accreditation.

Risks and strategy

Mitigates risks via diversification of services, geographic expansion, partnerships, and robust governance.

Market Footprint

Top Clients

Top Clients

Serves B2C patients across India and international patients via OPD clinics in Africa and Middle East.

Top Products

Top Products

Comprehensive hospital services including orthopedics, cardiac care, neurology, oncology, renal transplants, and implant manufacturing.

Price Movement & Share Holding

Today's High/Low

120.5126.9

52 Week High/Low

110.61252.05
Past Returns

1 week

1.77%

1 month

-14.34%

3 month

-23.85%

1 year

-49.1%

3 year

-52.9%

5 year

-17.95%

Share Holding

Promoters

74.33%

FII

4.65%

DII

0.31%

Retail

13.9%

Others

6.81%

Company Overview

Founded Year

2004

Listed Year

2017

Headquarter

Ahmedabad, Gujarat, India

MD/CEO

Dr. Vikram Shah

Website

https://www.shalby.org/

Price Movement & Share Holding

Today's High/Low

120.5126.9

52 Week High/Low

110.61252.05

Past Returns

1 week

1.77%

1 month

-14.34%

3 month

-23.85%

1 year

-49.1%

3 year

-52.9%

5 year

-17.95%

Share Holding

Promoters

74.33%

FII

4.65%

DII

0.31%

Retail

13.9%

Others

6.81%

Company Facts

What we do

Shalby Limited is a leading Indian multi-specialty hospital chain providing affordable, high-quality healthcare including orthopedics, cardiology, oncology, and transplants across 15 hospitals.

Founded in

2004

Market share

Largest corporate hospital group in Western and Central India with 2300+ beds over 12 cities; global leader in joint replacements.

Problem solved

Provides advanced tertiary and quaternary healthcare addressing orthopedic and multi-specialty medical needs affordably.

Top clients or who we serve

Serves B2C patients across India and international patients via OPD clinics in Africa and Middle East.

Key management

Dr. Vikram Shah, renowned orthopedic surgeon and founder, leads with a focus on innovation and expansion.

Our journey and innovations

Evolved from a 6-bed hospital in 1994 to a 15-hospital network; pioneered digital transformation and advanced robotic surgeries.

Where we operate

Operates primarily in India across 12 cities and internationally in Africa, Middle East, and Southeast Asia.

Top products or what we offer

Comprehensive hospital services including orthopedics, cardiac care, neurology, oncology, renal transplants, and implant manufacturing.

Top brands

Shalby Hospitals, Shalby International, Shalby MedTech implants (including Tahoe Unicompartmental Knee System - TUKS)

Raw materials needed

Raw materials for implant manufacturing include medical-grade metals and biomaterials sourced globally.

Raw materials supplier

Implant raw materials sourced via subsidiaries in USA, Singapore, and India.

Recurring vs cyclical contribution

Revenue is largely recurring from hospital operations, with implant manufacturing adding manufacturing revenue stream.

Our industry position

Leading regional hospital chain with top market share in orthopedics and expanding multi-specialty care.

Financial highlights

FY25 consolidated revenue ₹1087 Cr; PAT ₹6.22 Cr; hospital segment EBITDA ₹96 Cr; continuing growth in revenue and capacity.

Geographical revenue split

Revenue majorly from India with growing contributions from international operations in Africa and Middle East.

Whats driving growth

Growth driven by expansion of hospitals, new specialty launches, advanced surgical technology, and implant business innovation.

Our future plans

Launching 175-bed Mumbai facility by FY30; expanding implant products globally; increasing AI and robotic surgery capabilities.

Our green promise

Implements energy conservation measures, sustainable building design, and water conservation in new hospital projects.

Our people and values

Employs 4600+ staff focused on patient care, technological excellence, and ethical governance.

Key challenges ahead

Challenges include scaling operations sustainably, managing costs, and navigating healthcare regulations.

Interesting facts

Global leader in joint replacement surgeries with 175,000+ done; first hospital group with NABH ambulance accreditation.

Risks and strategy

Mitigates risks via diversification of services, geographic expansion, partnerships, and robust governance.

Market Footprint

Top Clients

Top Clients

Serves B2C patients across India and international patients via OPD clinics in Africa and Middle East.

Top Products

Top Products

Comprehensive hospital services including orthopedics, cardiac care, neurology, oncology, renal transplants, and implant manufacturing.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions